{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:54:13Z","timestamp":1789012453201,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T00:00:00Z","timestamp":1614643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012041","name":"Versus Arthritis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry & Cell Biology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.biocel.2021.105961","type":"journal-article","created":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T12:48:10Z","timestamp":1614602890000},"page":"105961","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Selective deletion of connective tissue growth factor attenuates experimentally-induced pulmonary fibrosis and pulmonary arterial hypertension"],"prefix":"10.1016","volume":"134","author":[{"given":"Angela Y.Y.","family":"Tam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L.","family":"Horwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9047-1698","authenticated-orcid":false,"given":"Sarah L.","family":"Trinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korsa","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Voon","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3975-8938","authenticated-orcid":false,"given":"Christopher P.","family":"Denton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill T.","family":"Norman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1612-5695","authenticated-orcid":false,"given":"Alan M.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Bou-Gharios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 5","key":"10.1016\/j.biocel.2021.105961_bib0005","doi-asserted-by":"crossref","first-page":"v8","DOI":"10.1093\/rheumatology\/ken278","article-title":"Connective tissue growth factor: growth factor, matricellular organizer, fibrotic biomarker or molecular target for anti-fibrotic therapy in SSc?","volume":"47","author":"Abraham","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.biocel.2021.105961_bib0010","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/art.1780340913","article-title":"Expression and function of surface antigens on scleroderma fibroblasts","volume":"34","author":"Abraham","year":"1991","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.biocel.2021.105961_bib0015","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11926-007-0008-z","article-title":"New developments in fibroblast and myofibroblast biology: implications for fibrosis and scleroderma","volume":"9","author":"Abraham","year":"2007","journal-title":"Curr. Rheumatol. Rep."},{"issue":"8","key":"10.1016\/j.biocel.2021.105961_bib0020","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.2215\/CJN.09321209","article-title":"Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria","volume":"5","author":"Adler","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.biocel.2021.105961_bib0025","doi-asserted-by":"crossref","first-page":"6554","DOI":"10.1096\/fj.202000240RR","article-title":"Blocking CTGF\/CCN2 reduces established skeletal muscle fibrosis in a rat model of overuse injury","volume":"34","author":"Barbe","year":"2020","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.biocel.2021.105961_bib0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12079-019-00529-3","article-title":"Caught between a \u201cRho\u201d and a hard place: are CCN1\/CYR61 and CCN2\/CTGF the arbiters of microvascular stiffness?","volume":"14","author":"Chaqour","year":"2020","journal-title":"J. Cell Commun. Signal."},{"issue":"10","key":"10.1016\/j.biocel.2021.105961_bib0035","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1164\/rccm.201103-0412OC","article-title":"A novel murine model of severe pulmonary arterial hypertension","volume":"184","author":"Ciuclan","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"24","key":"10.1016\/j.biocel.2021.105961_bib0040","article-title":"Semi-quantitative determination of protein expression using immunohistochemistry staining and analysis: an integrated protocol","volume":"9","author":"Crowe","year":"2019","journal-title":"Bio Protoc."},{"issue":"10103","key":"10.1016\/j.biocel.2021.105961_bib0045","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"issue":"27","key":"10.1016\/j.biocel.2021.105961_bib0050","doi-asserted-by":"crossref","first-page":"25109","DOI":"10.1074\/jbc.M300636200","article-title":"Fibroblast-specific expression of a kinase-deficient type II transforming growth factor beta (TGFbeta) receptor leads to paradoxical activation of TGFbeta signaling pathways with fibrosis in transgenic mice","volume":"278","author":"Denton","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.biocel.2021.105961_bib0055","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1002\/art.38078","article-title":"Endothelial injury in a transforming growth factor beta-dependent mouse model of scleroderma induces pulmonary arterial hypertension","volume":"65","author":"Derrett-Smith","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.biocel.2021.105961_bib0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012909","article-title":"A mouse strain where basal connective tissue growth factor gene expression can be switched from low to high","volume":"5","author":"Doherty","year":"2010","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.biocel.2021.105961_bib0065","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/qjmed\/hci078","article-title":"N-terminal connective tissue growth factor is a marker of the fibrotic phenotype in scleroderma","volume":"98","author":"Dziadzio","year":"2005","journal-title":"QJM"},{"issue":"2","key":"10.1016\/j.biocel.2021.105961_bib0070","first-page":"69","article-title":"The mighty fibroblast and its utility in scleroderma research","volume":"2","author":"Garrett","year":"2017","journal-title":"J. Scleroderma Relat. Disord."},{"issue":"7","key":"10.1016\/j.biocel.2021.105961_bib0075","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.ajpath.2015.03.019","article-title":"Endothelial to mesenchymal transition contributes to endothelial dysfunction in pulmonary arterial hypertension","volume":"185","author":"Good","year":"2015","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.biocel.2021.105961_bib0080","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/1346-8138.13156","article-title":"Biomarkers in systemic sclerosis: their potential to predict clinical courses","volume":"43","author":"Hasegawa","year":"2016","journal-title":"J. Dermatol."},{"issue":"1","key":"10.1016\/j.biocel.2021.105961_bib0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/exd.13806","article-title":"CCN proteins as potential actionable targets in scleroderma","volume":"28","author":"Henrot","year":"2019","journal-title":"Exp. Dermatol."},{"issue":"4","key":"10.1016\/j.biocel.2021.105961_bib0090","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0002-9440(10)62525-4","article-title":"Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis","volume":"159","author":"Howell","year":"2001","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.biocel.2021.105961_bib0095","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2144\/000112729","article-title":"Standardized quantification of pulmonary fibrosis in histological samples","volume":"44","author":"Hubner","year":"2008","journal-title":"Biotechniques"},{"issue":"2","key":"10.1016\/j.biocel.2021.105961_bib0100","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/1523-1747.ep12318465","article-title":"Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis","volume":"105","author":"Igarashi","year":"1995","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.biocel.2021.105961_bib0105","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2174\/157339710793205611","article-title":"Role of growth factors in the pathogenesis of tissue fibrosis in systemic sclerosis","volume":"6","author":"Jimenez","year":"2010","journal-title":"Curr. Rheumatol. Rev."},{"issue":"12","key":"10.1016\/j.biocel.2021.105961_bib0110","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/nrd3599","article-title":"Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets","volume":"10","author":"Jun","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.biocel.2021.105961_bib0115","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.044719","article-title":"Post-traumatic osteoarthritis development is not modified by postnatal chondrocyte deletion of Ccn2","volume":"13","author":"Keenan","year":"2020","journal-title":"Dis. Model. Mech."},{"issue":"5","key":"10.1016\/j.biocel.2021.105961_bib0120","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.yexcr.2006.12.006","article-title":"CCN2 is necessary for the function of mouse embryonic fibroblasts","volume":"313","author":"Kennedy","year":"2007","journal-title":"Exp. Cell Res."},{"issue":"7","key":"10.1016\/j.biocel.2021.105961_bib0125","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/annrheumdis-2011-200955","article-title":"Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis","volume":"71","author":"Khan","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.biocel.2021.105961_bib0130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s12079-016-0324-z","article-title":"Cell surface receptors for CCN proteins","volume":"10","author":"Lau","year":"2016","journal-title":"J. Cell Commun. Signal."},{"key":"10.1016\/j.biocel.2021.105961_bib0135","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/978-1-4939-6430-7_34","article-title":"CCN2 in skin fibrosis","volume":"1489","author":"Leask","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.biocel.2021.105961_bib0140","doi-asserted-by":"crossref","DOI":"10.1007\/s12079-020-00568-1","article-title":"Slow train coming: an anti-CCN2 strategy reverses a model of chronic overuse muscle fibrosis","author":"Leask","year":"2020","journal-title":"J. Cell Commun. Signal."},{"issue":"Pt 23","key":"10.1016\/j.biocel.2021.105961_bib0145","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1242\/jcs.03270","article-title":"All in the CCN family: essential matricellular signaling modulators emerge from the bunker","volume":"119","author":"Leask","year":"2006","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.biocel.2021.105961_bib0150","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-1-4939-7113-8_10","article-title":"Characterization of mesenchymal-fibroblast cells using the Col1a2 Promoter\/Enhancer","volume":"1627","author":"Li","year":"2017","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.biocel.2021.105961_bib0155","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12079-009-0081-3","article-title":"Connective tissue growth factor is induced in bleomycin-induced skin scleroderma","volume":"4","author":"Liu","year":"2010","journal-title":"J. Cell Commun. Signal."},{"issue":"1","key":"10.1016\/j.biocel.2021.105961_bib0160","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/art.30074","article-title":"CCN2 is required for bleomycin-induced skin fibrosis in mice","volume":"63","author":"Liu","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.biocel.2021.105961_bib0165","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13075-017-1356-3","article-title":"Anti-connective tissue growth factor (CTGF\/CCN2) monoclonal antibody attenuates skin fibrosis in mice models of systemic sclerosis","volume":"19","author":"Makino","year":"2017","journal-title":"Arthritis Res. Ther."},{"issue":"17","key":"10.1016\/j.biocel.2021.105961_bib0170","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1158\/0008-5472.CAN-17-3844","article-title":"CTGF mediates tumor-stroma interactions between hepatoma cells and hepatic stellate cells to accelerate HCC progression","volume":"78","author":"Makino","year":"2018","journal-title":"Cancer Res."},{"issue":"14","key":"10.1016\/j.biocel.2021.105961_bib0175","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.234039","article-title":"TGF-beta family ligands exhibit distinct signalling dynamics that are driven by receptor localisation","volume":"132","author":"Miller","year":"2019","journal-title":"J. Cell. Sci."},{"issue":"9","key":"10.1016\/j.biocel.2021.105961_bib0180","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/dvg.20335","article-title":"A global double-fluorescent Cre reporter mouse","volume":"45","author":"Muzumdar","year":"2007","journal-title":"Genesis"},{"issue":"2_suppl","key":"10.1016\/j.biocel.2021.105961_bib0185","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/2397198320903867","article-title":"Pathogenesis of systemic sclerosis associated interstitial lung disease","volume":"5","author":"Nihtyanova","year":"2020","journal-title":"J. Scleroderma Relat. Disord."},{"issue":"13","key":"10.1016\/j.biocel.2021.105961_bib0190","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.227900","article-title":"The myofibroblast at a glance","volume":"133","author":"Pakshir","year":"2020","journal-title":"J. Cell. Sci."},{"issue":"6","key":"10.1016\/j.biocel.2021.105961_bib0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218178","article-title":"Yin\/Yang expression of CCN family members: transforming growth factor beta 1, via ALK5\/FAK\/MEK, induces CCN1 and CCN2, yet suppresses CCN3, expression in human dermal fibroblasts","volume":"14","author":"Peidl","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biocel.2021.105961_bib0200","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12079-018-0455-5","article-title":"The concept of the CCN protein family revisited: a centralized coordination network","volume":"12","author":"Perbal","year":"2018","journal-title":"J. Cell Commun. Signal."},{"issue":"2","key":"10.1016\/j.biocel.2021.105961_bib0205","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1096\/fj.201800622RR","article-title":"Genetic manipulation of CCN2\/CTGF unveils cell-specific ECM-remodeling effects in injured skeletal muscle","volume":"33","author":"Petrosino","year":"2019","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.biocel.2021.105961_bib0210","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1002\/art.24620","article-title":"Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen","volume":"60","author":"Ponticos","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.biocel.2021.105961_bib0215","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.biocel.2007.01.006","article-title":"Transforming growth factor-beta\/connective tissue growth factor axis in the kidney","volume":"40","author":"Qi","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.biocel.2021.105961_bib0220","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.matbio.2018.03.007","article-title":"Connective tissue growth factor (CTGF) from basics to clinics","volume":"68-69","author":"Ramazani","year":"2018","journal-title":"Matrix Biol."},{"issue":"1","key":"10.1016\/j.biocel.2021.105961_bib0225","first-page":"149","article-title":"Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis","volume":"27","author":"Sato","year":"2000","journal-title":"J. Rheumatol."},{"issue":"7","key":"10.1016\/j.biocel.2021.105961_bib0230","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.biocel.2021.105961_bib0235","first-page":"1","article-title":"Pamrevlumab for the treatment of idiopathic pulmonary fibrosis","author":"Sgalla","year":"2020","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"1","key":"10.1016\/j.biocel.2021.105961_bib0240","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1006\/excr.2000.4972","article-title":"Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis","volume":"259","author":"Shi-wen","year":"2000","journal-title":"Exp. Cell Res."},{"issue":"5","key":"10.1016\/j.biocel.2021.105961_bib0245","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/art.27382","article-title":"Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis","volume":"62","author":"Sonnylal","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"Pt 10","key":"10.1016\/j.biocel.2021.105961_bib0250","first-page":"2164","article-title":"Connective tissue growth factor causes EMT-like cell fate changes in vivo and in vitro","volume":"126","author":"Sonnylal","year":"2013","journal-title":"J. Cell. Sci."},{"issue":"6","key":"10.1016\/j.biocel.2021.105961_bib0255","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1161\/HYPERTENSIONAHA.114.03279","article-title":"Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure","volume":"63","author":"Szabo","year":"2014","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.biocel.2021.105961_bib0260","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1523-1747.2003.12308.x","article-title":"Sustained activation of fibroblast transforming growth factor-beta\/Smad signaling in a murine model of scleroderma","volume":"121","author":"Takagawa","year":"2003","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.biocel.2021.105961_bib0265","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s12079-017-0414-6","article-title":"An early history of CCN2\/CTGF research: the road to CCN2 via hcs24, ctgf, ecogenin, and regenerin","volume":"12","author":"Takigawa","year":"2018","journal-title":"J. Cell Commun. Signal."},{"issue":"11","key":"10.1016\/j.biocel.2021.105961_bib0270","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1093\/rheumatology\/kes191","article-title":"Gut fibrosis with altered colonic contractility in a mouse model of scleroderma","volume":"51","author":"Thoua","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.biocel.2021.105961_bib0275","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biocel.2021.105961_bib0280","first-page":"46","article-title":"Mouse models of bleomycin-induced pulmonary fibrosis","volume":"5","author":"Walters","year":"2008","journal-title":"Curr. Protoc. Pharmacol."},{"issue":"1","key":"10.1016\/j.biocel.2021.105961_bib0285","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1755-1536-4-4","article-title":"Cooperative interaction of CTGF and TGF-beta in animal models of fibrotic disease","volume":"4","author":"Wang","year":"2011","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.biocel.2021.105961_bib0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172588","article-title":"CTGF: a potential therapeutic target for Bronchopulmonary dysplasia","volume":"860","author":"Wang","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.biocel.2021.105961_bib0295","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/MCP.0000000000000712","article-title":"Progressive fibrosing interstitial lung disease: treatable traits and therapeutic strategies","volume":"26","author":"Wongkarnjana","year":"2020","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.biocel.2021.105961_bib0300","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/978-981-13-8871-2_17","article-title":"Connective tissue growth factor and renal fibrosis","volume":"1165","author":"Yin","year":"2019","journal-title":"Adv. Exp. Med. Biol."}],"container-title":["The International Journal of Biochemistry & Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272521000455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272521000455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T07:20:34Z","timestamp":1761204034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272521000455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":60,"alternative-id":["S1357272521000455"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2021.105961","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective deletion of connective tissue growth factor attenuates experimentally-induced pulmonary fibrosis and pulmonary arterial hypertension","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2021.105961","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105961"}}